| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |